Financials

  • Market Capitalization 402.54 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.14
市销率
26.03

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3051
LRMR
Larimar Therapeutics, Inc. - Common Stock
4.01 USD-0.99%-2.91%+5.25%+2.30%416.57 M USD
3061
GALT
Galectin Therapeutics Inc. - Common Stock
4.07 USD-1.69%+9.41%+18.66%-3.10%410.46 M USD
3076
CTNM
Contineum Therapeutics, Inc. - Common stock
17.39 USD+0.81%+1.28%+22.72%+13.88%401.69 M USD
3088
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
13.57 USD-1.67%+2.42%+8.04%+56.16%395.23 M USD

新闻